Pharmafile Logo

Making a difference together

August 8, 2016 |  

It was highlighted at the 2016 World Economic Forum that ‘good business’ now means more than financial success, with multiple stakeholders asking how business will benefit society. At Lucid, our vision is to deliver medical education that changes healthcare professional’s (HCPs) behaviour and so improves patients’ lives. All of our stakeholders – pharma partners, HCPs and the internal Lucid team – identify with and aspire to this vision.  

Education that simply raises awareness of clinical care gaps through traditional methods, without changing behaviour, is no longer enough. Our pharma partners need to demonstrate return on investment: a measurable improvement in patients’ health. HCPs need to explore new ways to share and adopt best practice behaviour. Together, we are advancing the boundaries of medical education.  

Lucid’s Advance Outcomes methodology includes identifying behaviour barriers and tailoring education to overcome these. This forward-thinking approach has been acknowledged by the industry. Most recently, Lucid was highly commended in the ‘Communications Consultancy of the Year’ category at the annual Communique Awards. While we are proud to be part of an award-winning agency, we are prouder of our vision to improve patients’ lives. But we don’t rest on our laurels. We challenge ourselves to continue to be at the forefront of this evolution in medical education, and strive to inspire all our stakeholders to take this exciting and worthwhile journey with us.

You can read the full article published in the July / August PME here
- PMLiVE

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

My Lucid journey from PMW to Head of Medical

Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced...

Listen, learn and lift off

In April’s PME, Danny Buckland has been talking to industry leaders about launch excellence in the featured article, Listen, learn and lift off.Buckland points out that pandemic storms have changed the...

Launch excellence

In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines...

Meet The Lucid Group Talent Team

Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 2)

In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 1)

Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on...

My Journey into MedComms #LucidLife

I began as a medical writer after almost a decade working in medical publishing as a production editor. Whilst working in publishing, I was exposed to lots of different writing...

International Women's Day 2022 #BreakTheBias

Today is International Women’s Day. This day is about gender equality, which, to be achieved, must involve the calling out of gender bias, discrimination and stereotyping.Individually, we're all responsible for...